$45.3M
11-50
Ribometrix develops small molecule drugs for human diseases, using a platform approach. Their innovative therapeutics aim to treat a variety of conditions, offering new hope for patients in need of effective treatments.
National Rank
Share
Loading...
In United States
out of startups
Regional Rank
Share
Loading...
In North America
out of startups
City Rank
Share
2nd
In Greenville
out of 13 startups
National Rank
Share
2,343rd
In United States
out of 8871 startups
Regional Rank
Share
2,455th
In North America
out of 9667 startups
City Rank
Share
2nd
In Greenville
out of 5 startups
National Rank
Share
1,001st
In United States
out of 3471 startups
Regional Rank
Share
1,035th
In North America
out of 3719 startups
rankings by:
Not enough data points to display the chart.
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...